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Background: Head and neck cancer are one of the most common neoplasm pathologies in humans. The aim of this 
study was to analyze the type, characteristics, treatment and evolution of oral neoplasm or precancerous lesion 
in a sample of Andalusian population (Spain) derived from the Oncology Rehabilitation Hospital Unit during a 
period of 20 years. 
Material and Methods: A retrospective descriptive study was carried out during the years 1991 and 2011 analyzing 
the type, characteristics, treatment and follow-up of oral neoplasm in the Oral and Maxillofacial Surgery Unit of 
the Universitary Hospital “Virgen del Rocío”. The inclusion criteria were patients whose underlying pathology 
was any type of benign or malignant neoplasm or presence of precancerous lesion that, after treatment, had been 
referred to the Prosthetic Rehabilitation Unit. 
Results: Of the initial analyzed sample of 60 patients, only 45 patients met the inclusion criteria. Of the final 
sample analyzed, 31 subjects were men (68.9%) and 14 women (31.1%) (p = 0.0169). The mean age of the sample 
was 57 years ± 13.83, been more frequently in older people with more than 50 years (73.3%) (p = 0.0169). The most 
common type of neoplasm was epidermoid carcinoma (64.4%). The site most frequently found in squamous cell 
carcinoma was the floor of the mouth (31%). The most frequent treatment modality was surgery with postopera-
tive radiotherapy (42.2%). All patients had a minimum follow-up of 5 years, and a recurrence in this period was 
identified in 11.1% of the sample. Multivariate logistic regression showed a statistically significant association for 
the variables age (p = 0.0063) and smoking (p = 0.0434). 
Conclusions: Epidermoid carcinoma is the most frequent tumor in the oral cavity, where increase age and smoking 
are confirmed as associated risk factors.
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Introduction 
Head and neck cancer are one of the most common neo-
plasm pathologies in humans, accounting for 3% of all 
types of cancers. Approximately 48% of the cases are 
located in the oral cavity, of which 90% correspond to 
squamous cell carcinoma (1,2). 
This pathology affects largely of the population of mid-
dle and advanced age, where 90% occurs in people over 
40 years of age, with predominance between 55 and 70 
years (3). The etiology is of unknown origin although 
it has been shown that squamous cell carcinoma from 
the oropharyngeal cavity is associated with high fre-
quency with tobacco consumption, alcohol abuse and 
poor nutritional status. Smoking increases by approxi-
mately six-fold the relative risk of oral cancer versus 
non-smokers (4).
The location of the primary tumour determines the be-
havior and prognosis which leads to the execution of a 
particular type of treatment. The treatment plan is eval-
uated individually in a committee specialized in head 
and neck tumors. The TNM classification is the most 
used to study and homogenize the diagnosis and treat-
ment of tumours (5).
The main objective of cancer treatment is patient survival, 
although restoration of altered functions and aesthetics 
through reconstructive surgery and / or subsequent reha-
bilitation with removable prosthesis or osseointegrated im-
plants must be taken into account. Treatment of squamous 
cell carcinoma of the head and neck depends on the stage 
of the tumour. In the initial stages, a single treatment of 
surgery or radiotherapy may be sufficient. In contrast, 
unimodal treatments often fail in advanced stages. Despite 
correct treatment with conventional surgery and radiother-
apy, the rate of loco-regional recurrence is approximately 
50% to 60% and the rate of metastasis is between 20% 
and 40% (6). Among the major causes of morbidity and 
mortality are local invasion and regional lymphatic spread, 
metastases are considered a less frequent cause.
The objective of this research was to analyze type, 
characteristics, treatment and evolution of oral benign 
or malignant neoplasm or presence of precancerous le-
sion in a sample of the Andalusian population (Spain) 
derived from the Oncology Rehabilitation Hospital Unit 
during a period of 20 years.
Material and Methods
An observational retrospective descriptive study was 
carried out during the years 1991 and 2011 analyzing 
the type, characteristics, treatment and follow-up of oral 
benign or malignant neoplasm or presence of precan-
cerous lesion. The sample consisted of patients whose 
tumour had previously been removed and who had been 
referred to the Prosthetic Rehabilitation Department of 
the Oral and Maxillofacial Surgery Unit of the Univer-
sitary Hospital “Virgen del Rocío” (Seville, Spain).  
The inclusion criteria were patients whose underlying pa-
thology was any type of benign or malignant neoplasm or 
presence of precancerous lesion, which after their treat-
ment and during the period of time that comprised the 
present study would have been referred to the Oncology 
Rehabilitation Unit. Exclusion criteria were patients who 
had been rehabilitated prior to their pathology through 
implant prosthesis, that the rehabilitator treatment was 
contraindicated and those we were not able to obtain the 
information related to the studied variables.
The information obtained from patients included in the 
study was from the hospital clinical records of the On-
cology Rehabilitation Unit and was entered into a data 
collection sheet. The variables studied were: sex, age, 
smoking habit, alcoholic habit, base pathology, tumour 
location, treatment performed and presence of recur-
rence.
Smoking was assessed in 4 categories, smoking 0-10 
cigarettes per day, smoking 10-20 cigarettes per day, 
smoking 20-30 cigarettes per day and smoking more 
than 30 cigarettes per day.
For the evaluation of alcoholic habit was used the test of 
identification of alcoholic disorders (AUDIT) (7). Risk 
categories in the typical consumption table were: low-
risk drinkers, ≤17 SDU (170g) for females and ≤ 28 SDU 
(280g) for males per week; Moderate-risk drinkers, > 
17 SDU for females and > 28 SDU for males per week; 
And high-risk drinkers, > 28 SDU for females and > 42 
SDU for males per week (8).
The present study was authorized by the Ethics Com-
mittee of the University of Seville, and the patients 
signed their consent for their clinical data to be used for 
scientific purposes, although the patients could not be 
identified. Statistical analysis of the variables studied 
was performed using the SPSS program. A chi-square 
test (for the study of the distribution of the different 
variables in the sample) and univariate and multivari-
ate logistic regressions (to identify risk factors for onco-
logical pathology) were carried out.
Results
Of the initial analyzed sample of 60 patients, only 45 
patients met the inclusion criteria. Of the final sample 
analyzed, 31 subjects were men (68.9%) and 14 women 
(31.1%) (p = 0.0169). The mean age of the sample was 57 
± 13.83, being more frequent the presence of head and 
neck cancer in people over 50 years (73.3%) compared 
to people under 50 years of age (26.7%) (p = 0.0169). 
The different analyzed variables disaggregated by age 
are found in Table 1.
Of the total sample of 45 patients, 57.8% had a history 
of smoking, of which 6.6% were smokers of 0-10 ciga-
rettes per day, 22.2% were smokers of 10-20 cigarettes 
per day, 11.1% were smokers of 20-30 cigarettes a day 
and 17.8% smoked more than 30 cigarettes a day.
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In relation to alcoholic habits, of the total sample stud-
ied, 40% had a history of alcoholic habits, 6% were pru-
dent drinkers, 17.8% were moderate drinkers and 15.5% 
were excessive drinkers.
The most common pathology was epidermoid carci-
noma (64.4%). Among the pathologies found less fre-
quently were ameloblastoma, odontogenic keratocystic 
tumor, rabdiomyosarcoma, leiomyosarcoma and cavum 
lymphoepithelioma, with a respective frequency of 
2.2%.
The most frequent localization found on squamous cell 
carcinoma was floor of the mouth (31%), tongue (17.2%), 
maxillary maxillary (13.7%) and retromolar trigone 
(13.7%) (Table 1). Among the less frequent locations we 
could found were hard palate (6.8%), mandible, gingiva, 
amygdala, nasal fossa and soft-uvula palate (3.4%) re-
spectively.
The most frequent treatment modality of the sample stud-
ied was surgery with postoperative radiotherapy (42.2%), 
followed by surgery as the only treatment (40%) and only 
13.3% of the cases were performed after surgery a com-
bination of radiotherapy with chemotherapy.
Of the sample studied, all patients had a minimum fol-
low-up of 5 years, during this period only 5 patients in 
the sample studied presented recurrence of tumor pa-
thology (11.1%), being more frequent in patients with 
a range between 50-60 years (80%). Of the 33 patients 
that could be evaluated during a period of 10-15 years, 
only 3 patients presented tumour recurrence (9%). With 
a period of 10-15 years, 20 patients could be evaluated 
and none of them had relapsed. A total of 9 patients with 
a follow-up greater than 15 years could be evaluated, 
of which only 1 patient had recurrence of oral tumour 
(12.5%).
Age 20-29 30-39 40-49 50-60 > 60 Total
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  Relapse 0-5 years 4 1 5 (11.1%)
Table 1: Analysis of studied variables by age.
Nº= number; carc.= carcinoma; S.C.C.= squamous cell carcinoma; surg.=surgical; radio. = radiotherapy; chem.= chemotherapy.
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The univariate logistic regressions showed a statistical-
ly significant association for the independent variables, 
age (p = 0.0169), sex (p = 0.0476), smoking (p = 0.0019) 
and alcoholic habit (p = 0.0106) with the dependent 
variable squamous cell carcinoma (Tables 2,3)
The multivariate logistic regression according to the in-
dependent variables, age, sex, smoking habit, alcoholic 
habit and relapse 0-5 years, with the dependent variable 
presence of squamous cell carcinoma, only continued to 
show a statistically significant association for the vari-
ables age (p = 0.0063) and smoking habit (p = 0.0434).
Discussion
The most common histology related to oral neoplasm 
was squamous cell carcinoma or epidermoid. Consid-
ered the malignant tumour of epithelial origin more 
common of the oral cavity. It is more frequent in men 
and the age of onset is usually between 50 and 70 years. 
Presence in children under 30 years of age is rare, al-
though an increase in women younger than 30 years has 
been observed without being related to smoking habit 
(1,2,9-11).
In industrialized countries, the ratio between male and 
female is 2: 1, because the most important risk fac-
tors, tobacco and alcohol, have been more established 
in men. This proportion is changing because women, 
in recent years, are acquiring largely these habits. This 
fact reveals that 51% of patients from the Unit of Pros-
thetic Rehabilitation of the University Hospital Virgen 
del Rocío were female.
Krishna et al. (12) studied the prevalence of oral neo-
plasm in Asian countries between the years 2000 and 
2012 and found an average age between 51-55 years. 
This is in agreement with our results where 40% of the 
patients attended at the unit had ages between 50-60 
years. 
Among the etiological factors of oral cavity neoplasm 
are smoking and alcohol consumption (13). Kuriakose 
et al. (14) observed in their study a small percentage of 
patients less than 45 years of age who did not smoke or 
drink and had epithelial dysplasias at the oral level. In 
our study, 57.8% of the patients studied had a history 
of smoking, although only 17.8% smoked more than 30 
cigarettes per day. In relation to the alcoholic habit, 40% 
of the total sample had history, where only 15.5% were 
excessive drinkers.
The role of alcohol as an independent predisposing fac-
tor in oral neoplasm has been discussed in the literature 
Explanatory variable B p Odds Ratio 95% LCL 95% UCL
Age 0.1157 0.0063       1.1226    1.0332    1.2199
Sex 1.0865    0.2924       2.9639    0.3922   22.4003
Smoking habit 2.4586    0.0434      11.6884    1.0752  127.0693
Alcoholic habit 0.5843    0.6532       1.7936    0.1402   22.9421
Relapse 0-5 years -0.3208    0.8238       0.7256    0.0431   12.2173
Table 3: Multivariate logistic regressions of the association of independent variables, 
age, sex (0 = woman, 1 = man), smoking habits (0 = no; 1 = yes), alcoholic habits (0 = no; 1 = yes) and relapse (0 = no; 1 = yes) on the 
dependent variable “type of tumor” (0 = no squamous cell carcinoma, 1 = if squamous cell carcinoma).
Explanatory variable B p Odds Ratio 95% LCL 95% UCL
Age 0.0712    0.0169       1.0738    1.0129    1.1385
Sex 1.3437    0.0476       3.8333    1.0143   14.4871
Smoking habit 2.2437    0.0019       9.4286    2.2891   38.8353
Alcoholic habit 2.1535    0.0106       8.6154    1.6505   44.9718
Relapse 0-5 years 0.8755    0.4523       2.4000    0.2448   23.5319
Table 2: Univariate logistic regressions of the association of independent variables, 
age, sex (0 = woman, 1 = man), smoking habits (0 = no; 1 = yes), alcoholic habits (0 = no; 1 = yes) and relapse (0 = no; 1 = yes) on the 
dependent variable “type of tumor” (0 = no squamous cell carcinoma, 1 = if squamous cell carcinoma).
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(15). On the contrary, it is obvious that alcohol increases 
the risk of cancer in a patient with regular tobacco con-
sumption; both factors have a carcinogenic and syner-
gistic effect (16). The results of our study are congruent 
with those found in the literature, univariate logistic 
regressions found a statistically significant associa-
tion between smoking (p = 0.0019, OR = 9.4), alcoholic 
habit (p = 0.0106, OR = 8.6) and suffer from epider-
moid carcinoma. However, in the multivariate logistic 
regression only the smoking habit continued to present 
a statistically significant association (p = 0.0434; O.R = 
11.6884).
Sanchis et al. (17) collected information on the preva-
lence of oral cancer and found that 38.8% appeared in 
the tongue (22.5% in the initial two thirds of the tongue), 
26% in the floor of the mouth, 9.5% In the oral mucosa, 
8.9% in gingiva, 8.8% in palate and 8% in the retromo-
lar trigone and the tonsillar pillar. Similarly, Bodner et 
al. (18) in a review of 186 cases collected over 20 years 
of squamous cell carcinoma found that 38% were on the 
tongue, followed by the floor of the mouth with 26%. 
This does not match with our results, since a higher 
prevalence of squamous cell carcinoma was found in 
the floor of the mouth (31%).
The treatment of cancer in the oral cavity is mainly 
based in resective surgery, which usually involves an 
important anatomical alteration in the development of 
certain basic functions for the daily life of the patient, 
such as speech and chewing. In case the patient has re-
ceived radiotherapy, other alterations may appear, such 
as damage of the patient’s own mucosa, xerostomia or 
possible dental caries. All this induce in the oral cavity 
an altered anatomical configuration that affect signifi-
cantly the quality of life of the patients (19,20).
Fletcher et al. (21) in 1970 already published the first 
evidence of the benefit of combine radiotherapy and 
surgical treatment in the treatment of oral cavity carci-
noma. This led to an in-depth study of this modality of 
treatment showing an increase treatment success with 
the application of postoperative radiation therapy. This 
combination therapy is mainly applied in patients with 
a high risk of relapse or metastasis that ha to be treated 
with more aggressive treatment (22).
Berneir et al. (23) performed a randomized study of 334 
patients with stage III or IV stage III or IV cancer. They 
observed a 5-year survival greater in the combined 
treatment group of radiotherapy and postoperative 
chemotherapy than in the group of post-surgical radio-
therapy. Although a greater adverse effects were found 
such as severe xerostomia, muscular fibrosis and mu-
cosal necrosis. In our study, 13.3% of the patients in the 
sample received a combined treatment of radiotherapy 
and chemotherapy.
Licitra et al. (24) suggest that neoadjuvant chemother-
apy may play an important role in the preservation of 
function and thus avoid radiotherapy for younger pa-
tients with oral cancer. However, the American Society 
of Clinical Oncology (ASCO) at the annual meeting in 
2012 presented data in which it sees no advantage over 
neoadjuvant chemotherapy prior to the combination of 
chemotherapy and radiotherapy (25).
The survival of cancer today is a reality, although the 
values may vary depending on the type of injury and the 
time of diagnosis. In our unit, 11% of patients suffered 
relapse in the first 5 years. Of the 9 patients with a follow-
up period of more than 15 years, 8 patients remained free 
of disease during this period (88.9%). The difference in 
the total number of patients per follow-up period is due 
to the fact that since the treatment date, this was the time 
that it was possible to count. Gastrom (26) in his 2005 
study assessed the follow-up of 107 patients for 25 years, 
and observed an average survival of 16 years after the 
treatment of the underlying pathology.
Conclusions
Epidermoid carcinoma is the most frequent tumour in 
the oral cavity, mainly found in the floor of the mouth, 
where advanced age and smoking are confirmed as as-
sociated risk factors.
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